Regulatory Alerts2018-12-11
Added · Updated
FS20/2: Patient Capital and Authorised Funds
The Financial Conduct Authority issued this feedback statement to provide final guidance on patient capital and authorised funds following the consultation in DP18/10. The document outlines the regulator's responses to stakeholder comments and details the specific changes to rules and expectations regarding long-term investment strategies. It establishes the definitive framework for firms managing authorised funds to align with the FCA's objectives for fostering patient capital in the UK market.
Topics
Share